Old Web
English
Sign In
Acemap
>
authorDetail
>
Li Xu
Li Xu
European Automobile Manufacturers Association
Adverse effect
Lung cancer
Medicine
Pathology
Cell
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC).
2019
Journal of Clinical Oncology
Qing Zhou
Lin Wu
Luo Feng
Tongtong An
Ying Cheng
Jianying Zhou
Junling Li
Ji-feng Feng
Li Zhang
Baohui Han
Walson Xu
Lvyu Zhu
Li Xu
Xiao Xu
Feng Roger Luo
Yi-Long Wu
Show All
Source
Cite
Save
Citations (4)
A Modified Phase 1 Clinical Trial of Abivertinib (Ac0010), a Third-Generation EGFR Tyrosine Kinase Inhibitor, in Chinese Patients with EGFR-T790M-positive Non-Small Cell Lung Cancer
2018
Social Science Research Network
Qing Zhou
Xiao-Qing Liu
Pei Hu
Jianying Zhou
Li Zhang
Tong-Tong An
Lin Wu
Ying Cheng
Ji Jiang
Zhi-Hong Chen
Bin Gan
Wanhong Xu
Feng R Luo
Li Xu
Xiao Xu
Yi-Long Wu
Show All
Source
Cite
Save
Citations (0)
How to achieve non-repudiation of origin with privacy protection in cloud computing
2013
Journal of Computer and System Sciences
Wei Wu
Jianying Zhou
Yang Xiang
Li Xu
Show All
Source
Cite
Save
Citations (0)
1